A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

Clinical trial NCT00758680 · TERMINATED

Trial details

NCT number: NCT00758680
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2008-08-01
Primary completion: 2010-03-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.